EP0729343A1 - Cold-water emulsifiable agents - Google Patents

Cold-water emulsifiable agents

Info

Publication number
EP0729343A1
EP0729343A1 EP95900674A EP95900674A EP0729343A1 EP 0729343 A1 EP0729343 A1 EP 0729343A1 EP 95900674 A EP95900674 A EP 95900674A EP 95900674 A EP95900674 A EP 95900674A EP 0729343 A1 EP0729343 A1 EP 0729343A1
Authority
EP
European Patent Office
Prior art keywords
weight
composition according
emulsions
oil
esters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP95900674A
Other languages
German (de)
French (fr)
Inventor
Achim Ansmann
Rolf Kawa
Helga Gondek
Gabriele Strauss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Publication of EP0729343A1 publication Critical patent/EP0729343A1/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39Derivatives containing from 2 to 10 oxyalkylene groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Definitions

  • the invention relates to cold water emulsifiable agents based on castor oil derivatives, oil bodies and magnesium soaps, emulsions containing these agents, a process for the preparation of these emulsions and the use of the agents for the preparation of emulsions.
  • Oil bodies with high or low polarity can only be satisfactorily emulsified with water and emulsifiers of the type mentioned if metal soaps are present. However, since these can only be worked into the fat phase when hot, the advantage in terms of energy and time savings in cold emulsification is lost.
  • a manufacturer of cosmetic or pharmaceutical emulsions who intends to use very polar or very nonpolar oil bodies has therefore been forced to melt the fat phase (oil + emulsifier + optionally co-emulsifier) at temperatures around 100 ° C., the stabilizer enter and then add the aqueous phase.
  • the object of the invention was therefore to provide the manufacturer of emulsions with a means which can be emulsified in the cold with water, optionally with the addition of a further oil phase, the complex step of hot emulsification being thus reliably avoided can.
  • the invention relates to cold water emulsifiable agents containing
  • mixtures which contain components a), b) and c) are stable even after prolonged storage and show no segregation.
  • the agents can be emulsified in the cold with aqueous phases, which in turn results in stable emulsions.
  • the invention includes the knowledge that only magnesium soaps are suitable as stabilizers for the production of the cold water emulsifiable agents; If aluminum and / or zinc soaps are used in the same recipes, agents are obtained which do not have sufficient storage stability, separate and cannot be marketed.
  • Suitable emulsifiers which form component a) are addition products of on average 5 to 15, preferably 6 to 9, mol of ethylene oxide onto hydrogenated (“hardened”) castor oil.
  • the proportion of emulsifiers in the agents according to the invention can usually make up 10 to 40 and preferably 25 to 35% by weight. Oil body
  • Suitable oil bodies which represent component b) are all liquid, water-insoluble, branched or linear, physiologically compatible aliphatic hydrocarbons, linear and / or branched alcohols, ethers or esters at ambient temperature (20 ° C.). Solid or higher-melting paraffins, esters, waxes or fats can also be used.
  • Suitable aliphatic hydrocarbons are squalane, squalenes, dioctylcyclohexane, di-n-octyl ether, di-2-ethylhexyl ether, paraffinum perliquidum, paraffinum subliquidum and isohexadecane (hydrogenated polybutylene).
  • Esters of trihydric and polyhydric alcohols in particular vegetable triglycerides, such as, for example, olive oil, almond oil, peanut oil, sunflower oil, synthetic triglycerides, such as, for example, Cg-Ci Q trifatty acid glycerol esters, or also the esters of pentaerythritol, are also particularly suitable as oil bodies eg pelargonic acid or oleic acid.
  • Oil bodies of the formulas (Ia) to (Ic) are known as cosmetic and pharmaceutical oil components and as lubricant and lubricant components.
  • the products which are liquid at ambient temperature (20 ° C.) are of the greatest importance.
  • Typical examples are the esters of ⁇ 2 ⁇ ⁇ 1 ⁇ fatty acids with isopropyl alcohol, such as isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl oleate.
  • Suitable monoesters are, for example, n-butyl stearate, n-hexyl laurate, n-octyl stearate, n-decyl oleate, isooctyl stearate, isononyl palmitate, isononyl isononanoate, 2-ethyl hexyl palmitate, 2-ethyl hexyl stearate, 2-octyldecyl aryl etherolate, ocyl paletate, erylatedylyl erylate, erylatedylyl erylate, cyl oleate, cyl oleate, cyl oleate, ethyl cylyl ether and also esters which are obtainable from technical aliphatic alcohol mixtures and technical aliphatic carboxylic acids, for example esters from saturated and unsaturated fatty alcohols with 12 to 22 carbon atoms
  • Suitable dicarboxylic acid esters of the formula (Ib) are, for example, di-n-butyl adipate, di-n-butyl sebacate, di- (2-ethylhexyl) adipate, di- (2-hexyldecyl) succinate and diisotridecylacelaate.
  • Suitable diol esters of the formula (Ic) are, for example, ethylene glycol dioleate, ethylene glycol diotridecanoate, propylene glycol di (2-ethylhexanoate), propylene glycol diisostearate, propylene glycol dipelargonate, butanol diisostearate and neopentyl glycol dicaprylate.
  • Branched primary alcohols such as those known under the name "Guerbet alcohols” ⁇ cf. A.J. O'Lennick et al., Soap Cosm.Chem.Spec. 52 (1987) ⁇ are known. Typical examples are 2-butyl octanol, 2-hexyl decanol or 2-0 octyl decanol, and also esters of Guerbet alcohols with long-chain aliphatic carboxylic acids, in particular stearic acid. Finally, so-called Guerbet carbonates come into consideration, as are described in German patent application DE-Al 40 40 154 (Henkel).
  • the proportion of the oil bodies in the agents according to the invention can usually make up 30 to 80 and preferably 60 to 70% by weight.
  • Magnesium soaps (component c) are substances which follow the formula (Ha) and / or (IIb)
  • R 4 COO (OH) Mg (Hb) in which R 4 CO represents a fatty acyl radical having 12 to 22 carbon atoms.
  • Typical examples are the magnesium salts of lauric acid, myristic acid, palmitic acid, oleic acid, behenic acid and erucic acid and technical Geraische such as Ci2 / 14 Ko l cos f ETTs äure or technical Fatty acid cuts. Neutral and / or basic magnesium stearate is preferably used.
  • Magnesium soaps in particular magnesium stearates, are commercial products, for example from Barlocher, Kunststoff / FRG.
  • the qualities "PM”, “AV”, “SW / F” and “Pharma” are considered, which have a proportion of 7.5% by weight. %, have a free fatty acid content of at most 3% by weight and a water content of at most 6% by weight.
  • the average grain size is preferably in the range from 7.5 to 12.5 ⁇ m, the surface in the range from 8 to 9 m / g and the vibrating weight in the range from 300 to 600 g / l.
  • the proportion of magnesium soaps in the agents according to the invention can usually make up 1 to 15 and preferably 5 to 10% by weight.
  • the agents according to the invention can contain co-emulsifiers as further ingredients, which are selected from the group of esters of fatty acids with glycerol, oligo- or polyglycerols and / or sorbitan.
  • co-emulsifiers as further ingredients, which are selected from the group of esters of fatty acids with glycerol, oligo- or polyglycerols and / or sorbitan.
  • Typical examples are technical mono- and / or Diesterge- mix of C6-C22 fatty änren with glycerol, technical mono-, di-, tri- and / or Tetraester of CSS C22 _Fetts ä ren go- with olive or polyglycerols which in turn have a degree of self-condensation in the range from 1.5 to 10 and technical mono-, di- and / or triester mixtures of C5-C22 fatty acids with sorbitan.
  • the proportion of co-emulsifiers in the agents according to the invention can usually amount to 0.5 to 20 and preferably 5 to 15% by weight.
  • the agents according to the invention are low viscosity, stable in storage and can be cold emulsified with aqueous phases.
  • the resulting emulsions are preferably W / O emulsions.
  • Another object of the invention therefore relates to emulsions containing 5 to 80, preferably 10 to 60% by weight of the agents according to the invention, 20 to 80, preferably 25 to 75% by weight of an aqueous phase and 0 to 50, preferably 0 up to 25% by weight of additives, with the proviso that the amounts given add up to 100% by weight.
  • the invention further relates to a process for the preparation of emulsions, in which 5 to 80, preferably 10 to 60% by weight of the agents according to the invention are mixed with 20 to 80, preferably 25 to 75% by weight of an aqueous phase and 0 to 50, preferably 0 to 25% by weight of additives, with the proviso that the amounts add up to 100% by weight, cold emulsified. If desired, further oil bodies, emulsifiers and auxiliaries can also be added and co-emulsified at this point.
  • aqueous phase means water and mixtures of water with lower alcohols, such as ethanol or isopropyl alcohol, or polyols, such as ethylene glycol, diethylene glycol, butylene glycol or glycerin.
  • the aqueous phase can also contain electrolyte salts, such as sodium chloride, magnesium chloride or magnesium sulfate.
  • cold emulsified means that the Formation of the emulsion at ambient temperature (20 ° C) can be carried out, so melting of the components is not necessary.
  • auxiliaries are understood to mean, for example, perfume oils, antioxidants, oxides and pigments, pH regulators, dyes and UV filters.
  • the invention relates to the use of the compositions according to the invention for the production of cosmetic or pharmaceutical emulsions, in which they can be present in amounts of 5 to 80, preferably 10 to 60% by weight, based on the emulsions.
  • AI adduct of an average of 7 moles of ethylene oxide onto hydrogenated castor oil (Dehymuls ( R ) HRE 7)
  • the recipe components D1 and D2 are sales products of CF Grünau, Illertissen / FRG.
  • the metal soaps were dissolved in mineral oil, the mixture was cooled to 85 ° C. and the other constituents were metered in, the sequence being uncritical. The dispersions were then cooled to room temperature. The storage took place at 45 ° C for a period of 4 weeks.
  • the composition of the formulations according to the invention (Examples 1 to 5) and of the comparison formulations (Examples VI to V5) can be found in Table 1.
  • the fat phase I was stirred homogeneously at ambient temperature and the aqueous phase II was added cold while stirring.
  • the emulsion was stirred for 5 to 10 minutes and then homogenized. Examples of emulsions are listed in Table 2:
  • Vi ⁇ Brookfield viscosity, RVF, 23 ° C,

Abstract

Proposed are agents containing: a) 10 to 40 wt. % addition product of 5 to 15 mol ethylene oxide to hydrogenated castor oil, b) 30 to 80 wt.% oil bases and c) 1-15 wt.% magnesium soap, provided that the components add up to 100 wt.%. The agents are characterized by a high stability in storage and can be emulsified with aqueous phases without heating.

Description

Kaltwassereπmlgierbare Mittel Cold water cleanable agents
Gebiet der ErfindungField of the Invention
Die Erfindung betrifft kaltwasseremulgierbare Mittel auf Ba¬ sis von Ricinusölderivaten, ölkörpern und Magnesiumseifen, Emulsionen, die diese Mittel enthalten, ein Verfahren zur Herstellung dieser Emulsionen sowie die Verwendung der Mittel zur Herstellung von Emulsionen.The invention relates to cold water emulsifiable agents based on castor oil derivatives, oil bodies and magnesium soaps, emulsions containing these agents, a process for the preparation of these emulsions and the use of the agents for the preparation of emulsions.
Stand der TechnikState of the art
In den letzten Jahren hat der Einsatz von W/O-Emulsionen für die Entwicklung moderner kosmetischer Cremes und Lotionen zu¬ nehmend an Bedeutung gewonnen. Zum Aufbau der ölphase der Emulsionen werden kosmetische olkörper unterschiedlicher Po¬ larität verwendet. Zur Herstellung einer wäßrigen Emulsion auf Basis von mittelpolaren ölen reicht es aus, die Fettphase und die wäßrige Phase kalt - d.h. ohne Aufschmelzen der Fett¬ phase - in Anwesenheit eines geeigneten Emulgators, bei¬ spielsweise eines Ricinusölderivates, zu vermischen (vgl. A. Ansmann, R.Kawa in Seifen-Öle-Fette-Wachse, 117, 518 (1991). Olkörper mit hoher oder niedriger Polarität lassen sich mit Wasser und Emulgatoren der genannten Art nur dann zufrieden¬ stellend emulgieren, wenn Metallseifen anwesend sind. Da sich diese jedoch nur heiß in die Fettphase einarbeiten lassen, geht der Vorteil in Bezug auf die Energie- und Zeitersparnis bei der Kaltemulgierung verloren. Ein Hersteller von kosme¬ tischen oder pharmazeutischen Emulsionen, der sehr polare oder sehr unpolare Olkörper einzusetzen beabsichtigt, ist daher bislang gezwungen, in jedem Fall die Fettphase (Öl + Emulgator + gegebenenfalls Co-Emulgator) bei Temperaturen um 100°C aufzuschmelzen, den Stabilisator einzutragen und danach die wäßrige Phase zuzugeben.In recent years, the use of W / O emulsions for the development of modern cosmetic creams and lotions has become increasingly important. Cosmetic oil bodies of different polarities are used to build up the oil phase of the emulsions. To prepare an aqueous emulsion based on medium-polar oils, it is sufficient to mix the fat phase and the aqueous phase cold - ie without melting the fat phase - in the presence of a suitable emulsifier, for example a castor oil derivative (cf. A. Ansmann , R.Kawa in Soap-Oil-Fat-Waxes, 117, 518 (1991). Oil bodies with high or low polarity can only be satisfactorily emulsified with water and emulsifiers of the type mentioned if metal soaps are present. However, since these can only be worked into the fat phase when hot, the advantage in terms of energy and time savings in cold emulsification is lost. A manufacturer of cosmetic or pharmaceutical emulsions who intends to use very polar or very nonpolar oil bodies has therefore been forced to melt the fat phase (oil + emulsifier + optionally co-emulsifier) at temperatures around 100 ° C., the stabilizer enter and then add the aqueous phase.
Die Aufgabe der Erfindung hat somit darin bestanden, dem Hersteller von Emulsionen ein Mittel zur Verfügung zu stel¬ len, das in der Kälte mit Wasser, gegebenenfalls unter Zugabe einer weiteren ölphase emulgierbar ist, wobei der aufwendige Schritt einer Heißemulgierung also zuverlässig vermieden wer¬ den kann.The object of the invention was therefore to provide the manufacturer of emulsions with a means which can be emulsified in the cold with water, optionally with the addition of a further oil phase, the complex step of hot emulsification being thus reliably avoided can.
Beschreibung der ErfindungDescription of the invention
Gegenstand der Erfindung sind kaltwasseremulgierbare Mittel, enthaltendThe invention relates to cold water emulsifiable agents containing
a) 10 bis 40 Gew.-% eines Anlagerungsproduktes von 5 bis 15a) 10 to 40 wt .-% of an adduct of 5 to 15
Mol Ethylenoxid an hydriertes Ricinusöl, b) 30 bis 80 Gew.-% Olkörper und c) 1 bis 15 Gew.-% Magnesiumseife, mit der Maßgabe, daß sich die Komponenten zu 100 Gew.-% ad¬ dieren.Moles of ethylene oxide to hydrogenated castor oil, b) 30 to 80% by weight of oil body and c) 1 to 15% by weight of magnesium soap, with the proviso that the components add up to 100% by weight.
Überraschenderweise wurde gefunden, daß Mischungen, die die Komponenten a), b) und c) enthalten, auch bei längerer Lage¬ rung stabil sind und keine Entmischung zeigen. Die Mittel lassen sich in der Kälte mit wäßrigen Phasen emulgieren, wo¬ bei wiederum stabile Emulsionen resultieren. Die Erfindung schließt die Erkenntnis ein, daß sich für die Herstellung der kaltwasseremulgierbaren Mittel ausschließlich Magnesiumseifen als Stabilisatoren eignen; bei Verwendung von Aluminium- und/ oder Zinkseifen in den gleichen Rezepturen werden Mittel er¬ halten, die keine ausreichende Lagerstabilität aufweisen, se¬ parieren und nicht vermarktet werden können.Surprisingly, it has been found that mixtures which contain components a), b) and c) are stable even after prolonged storage and show no segregation. The agents can be emulsified in the cold with aqueous phases, which in turn results in stable emulsions. The invention includes the knowledge that only magnesium soaps are suitable as stabilizers for the production of the cold water emulsifiable agents; If aluminum and / or zinc soaps are used in the same recipes, agents are obtained which do not have sufficient storage stability, separate and cannot be marketed.
EmulgatorenEmulsifiers
Als Emulgatoren, die die Komponente a) bilden, kommen Anla¬ gerungsprodukte von durchschnittlich 5 bis 15, vorzugsweise 6 bis 9 Mol Ethylenoxid an hydriertes ("gehärtetes") Ricinusöl in Betracht. Besonders bevorzugt ist ein Produkt mit der CTFA-Bezeichnung "PEG 7-Hydrogenated Castor Oil", das dem 7 EO-Addukt an gehärtetes Ricinusöl entspricht. Der Anteil der Emulgatoren an den erfindungsgemäßen Mitteln kann üblicher¬ weise 10 bis 40 und vorzugsweise 25 bis 35 Gew.-% ausmachen. OlkörperSuitable emulsifiers which form component a) are addition products of on average 5 to 15, preferably 6 to 9, mol of ethylene oxide onto hydrogenated (“hardened”) castor oil. A product with the CTFA name "PEG 7-Hydrogenated Castor Oil", which corresponds to the 7 EO adduct of hardened castor oil, is particularly preferred. The proportion of emulsifiers in the agents according to the invention can usually make up 10 to 40 and preferably 25 to 35% by weight. Oil body
Als olkörper, die die Komponente b) darstellen, kommen alle bei Umgebungstemperatur (20°C) flüssigen, wasserunlöslichen, verzweigten oder linearen, physiologisch verträglichen ali- phatischen Kohlenwasserstoffe, lineare und/oder verzweigte Alkohole, Ether oder Ester in Frage. Feste oder höherschmel¬ zende Paraffine, Ester, Wachse oder Fette können dabei mit¬ verwendet werden.Suitable oil bodies which represent component b) are all liquid, water-insoluble, branched or linear, physiologically compatible aliphatic hydrocarbons, linear and / or branched alcohols, ethers or esters at ambient temperature (20 ° C.). Solid or higher-melting paraffins, esters, waxes or fats can also be used.
Typische Beispiele für geeignete aliphatische Kohlenwasser¬ stoffe sind Squalan, Squalene, Dioctylcyclohexan, Di-n-octyl- ether, Di-2-ethylhexylether, paraffinum perliquidum, paraf- finum subliquidum und Isohexadecan (hydriertes Polybutylen) .Typical examples of suitable aliphatic hydrocarbons are squalane, squalenes, dioctylcyclohexane, di-n-octyl ether, di-2-ethylhexyl ether, paraffinum perliquidum, paraffinum subliquidum and isohexadecane (hydrogenated polybutylene).
Als Olkörper gut geeignet sind ferner Ester von drei- und mehrwertigen Alkoholen, insbesondere pflanzliche Triglyceri- de, wie z.B. Olivenöl, Mandelöl, Erdnußöl, Sonnenblumenöl, synthetische Triglyceride, wie z.B. Cg-CiQ-Trifettsäuregly- cerinester oder auch die Ester des Pentaerythrits mit z.B. Pelargonsäure oder ölsäure.Esters of trihydric and polyhydric alcohols, in particular vegetable triglycerides, such as, for example, olive oil, almond oil, peanut oil, sunflower oil, synthetic triglycerides, such as, for example, Cg-Ci Q trifatty acid glycerol esters, or also the esters of pentaerythritol, are also particularly suitable as oil bodies eg pelargonic acid or oleic acid.
Schließlich kommen als Olkörper auch Mono- und Diester von Fettsäuren der Formeln (Ia) bis (Ic) in Betracht,Finally, mono- and diesters of fatty acids of the formulas (Ia) to (Ic) are also suitable as oil bodies,
RicO-OR2 (Ia)RicO-OR 2 (Ia)
R2OOC-R3-COOR2 (Ic) in denen R^-CO für aliphatische Acylreste mit 8 bis 22 Kohlen¬ stoffatomen, R2 für Alkylreste mit 3 bis 22 Kohlenstoffatomen und R3 für Alkylengruppen mit 2 bis 16 Kohlenstoffatomen ste¬ hen, mit der Maßgabe, daß die Ester in Summe mindestens 12 und höchstens 40 Kohlenstoffatome enthalten.R 2 OOC-R 3 -COOR 2 (Ic) in which R ^ -CO stand for aliphatic acyl radicals with 8 to 22 carbon atoms, R 2 for alkyl radicals with 3 to 22 carbon atoms and R3 for alkylene groups with 2 to 16 carbon atoms, with the proviso that the total of the esters is at least 12 and contain at most 40 carbon atoms.
Olkörper der Formeln (Ia) bis (Ic) sind als kosmetische und pharmazeutische ölkomponenten sowie als Gleit- und Schmier¬ mittelbestandteile bekannt.Oil bodies of the formulas (Ia) to (Ic) are known as cosmetic and pharmaceutical oil components and as lubricant and lubricant components.
Unter den Mono- und Diestern der Formel (Ia) kommen den bei Umgebungstemperatur (20°C) flüssigen Produkten die größte Be¬ deutung zu. Typische Beispiele sind die Ester von ~ 2~~ 1~ Fettsäuren mit Isopropylalkohol, wie z.B. Isopropylmyristat, Isopropylpalmitat, Isopropylstearat, Isopropyloleat. Andere geeignete Monoester sind z.B. n-Butylstearat, n-Hexyllaurat, n-Octylstearat, n-Decyloleat, Isooctylstearat, Isononylpal- mitat, Isononylisononanoat, 2-Ethylhexylpalmitat, 2-Ethyl- hexylstearat, 2-Octyldecylpalmitat, Cetearylisononanoat, Oleyloleat, Oleylerucat, Erucyloleat sowie Ester, die aus technischen aliphatischen Alkoholgemischen und technischen aliphatischen Carbonsäuren erhältlich sind, z.B. Ester aus gesättigten und ungesättigten Fettalkoholen mit 12 bis 22 Kohlenstoffatomen und gesättigten und ungesättigten Fettsäu¬ ren mit 12 bis 22 Kohlenstoffatomen, wie sie aus tierischen und pflanzlichen Fetten und Ölen zugänglich sind. Geeignet sind auch natürlich vorkommende Monoester- bzw. Wachsester- Gemische, wie sie z.B. im Jojobaöl oder im Spermöl vorliegen.Among the mono- and diesters of the formula (Ia), the products which are liquid at ambient temperature (20 ° C.) are of the greatest importance. Typical examples are the esters of ~ 2 ~ ~ 1 ~ fatty acids with isopropyl alcohol, such as isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl oleate. Other suitable monoesters are, for example, n-butyl stearate, n-hexyl laurate, n-octyl stearate, n-decyl oleate, isooctyl stearate, isononyl palmitate, isononyl isononanoate, 2-ethyl hexyl palmitate, 2-ethyl hexyl stearate, 2-octyldecyl aryl etherolate, ocyl paletate, erylatedylyl erylate, erylatedylyl erylate, cyl oleate, cyl oleate, cyl oleate, ethyl cylyl ether and also esters which are obtainable from technical aliphatic alcohol mixtures and technical aliphatic carboxylic acids, for example esters from saturated and unsaturated fatty alcohols with 12 to 22 carbon atoms and saturated and unsaturated fatty acids with 12 to 22 carbon atoms, as are obtainable from animal and vegetable fats and oils are. Naturally occurring monoester or wax ester mixtures, such as those present in jojoba oil or sperm oil, are also suitable.
Geeignete Dicarbonsäureester der Formel (Ib) sind z.B. Di-n- butyladipat, Di-n-butylsebacat, Di-(2-Ethylhexyl)adipat, Di- (2-hexyldecyl)succinat und Diisotridecylacelaat. Geeignete Diolester der Formel (Ic) sind z.B. Ethylenglycoldioleat, Ethylenglycoldiiεotridecanoat, Propylenglycoldi-(2-ethylhexa- noat), Propylenglycoldiisostearat, Propylenglycoldipelargo- nat, Butanoldiisostearat und Neopentylglycoldicaprylat.Suitable dicarboxylic acid esters of the formula (Ib) are, for example, di-n-butyl adipate, di-n-butyl sebacate, di- (2-ethylhexyl) adipate, di- (2-hexyldecyl) succinate and diisotridecylacelaate. Suitable diol esters of the formula (Ic) are, for example, ethylene glycol dioleate, ethylene glycol diotridecanoate, propylene glycol di (2-ethylhexanoate), propylene glycol diisostearate, propylene glycol dipelargonate, butanol diisostearate and neopentyl glycol dicaprylate.
Weiterhin eignen sich als Olkörper verzweigte primäre Alko¬ hole wie sie unter der Bezeichnung "Guerbetalkohole" {vgl. A.J.O'Lennick et al., Soap Cosm.Chem.Spec. 52 (1987)} bekannt sind. Typische Beispiele sind 2-Butyloctanol, 2-Hexyldecanol oder 2-0ctyldecanol, sowie Ester von Guerbetalkoholen mit langkettigen aliphatischen Carbonsäuren, insbesondere Stea¬ rinsäure. Schließlich kommen auch sogenannte Guerbetcarbonate in Betracht, wie sie in der Deutschen Patentanmeldung DE-Al 40 40 154 (Henkel) beschrieben werden.Branched primary alcohols such as those known under the name "Guerbet alcohols" {cf. A.J. O'Lennick et al., Soap Cosm.Chem.Spec. 52 (1987)} are known. Typical examples are 2-butyl octanol, 2-hexyl decanol or 2-0 octyl decanol, and also esters of Guerbet alcohols with long-chain aliphatic carboxylic acids, in particular stearic acid. Finally, so-called Guerbet carbonates come into consideration, as are described in German patent application DE-Al 40 40 154 (Henkel).
Der Anteil der olkörper an den erfindungsgemäßen Mitteln kann üblicherweise 30 bis 80 und vorzugsweise 60 bis 70 Gew.-% ausmachen.The proportion of the oil bodies in the agents according to the invention can usually make up 30 to 80 and preferably 60 to 70% by weight.
MagnesiumseifenMagnesium soaps
Unter Magnesiumseifen (Komponente c) sind Stoffe zu verste¬ hen, die der Formel (Ha) und/oder (Ilb) folgen,Magnesium soaps (component c) are substances which follow the formula (Ha) and / or (IIb)
(R COO)2-Mg (Ha)(R COO) 2-Mg (Ha)
(R4COO)(OH)Mg (Hb) in der R4CO für einen Fettacylrest mit 12 bis 22 Kohlenstoff¬ atomen steht. Typische Beispiele sind die Magnesiumsalze von Laurinsäure, Myristinsäure, Palmitinsäure, ölsäure, Behen- säure und Erucasäure sowie deren technische Geraische, wie beispielsweise Ci2/14-Kolcosfettsäure oder technische Fettsäureschnitte. Vorzugsweise wird neutrales und/oder ba¬ sisches Magnesiumstearat eingesetzt.(R 4 COO) (OH) Mg (Hb) in which R 4 CO represents a fatty acyl radical having 12 to 22 carbon atoms. Typical examples are the magnesium salts of lauric acid, myristic acid, palmitic acid, oleic acid, behenic acid and erucic acid and technical Geraische such as Ci2 / 14 Ko l cos f ETTs äure or technical Fatty acid cuts. Neutral and / or basic magnesium stearate is preferably used.
Magnesiumεeifen, insbesondere auch Magnesiumstearate stellen Handelsprodukte beispielsweise der Fa.Bärlocher, München/FRG dar. In Betracht kommen die Qualitäten "PM", "AV", "SW/F" und "Pharma", die einen Anscheanteil von 7,5 Gew.-%, einen Gehalt an freier Fettsäure von maximal 3 Gew.-% und einen Wasserge¬ halt von maximal 6 Gew.-% aufweisen. Die mittlere Korngröße liegt vorzugsweise im Bereich von 7,5 bis 12,5 um, die Ober¬ fläche im Bereich von 8 bis 9 m /g und das Rüttelgewicht im Bereich von 300 bis 600 g/1.Magnesium soaps, in particular magnesium stearates, are commercial products, for example from Barlocher, Munich / FRG. The qualities "PM", "AV", "SW / F" and "Pharma" are considered, which have a proportion of 7.5% by weight. %, have a free fatty acid content of at most 3% by weight and a water content of at most 6% by weight. The average grain size is preferably in the range from 7.5 to 12.5 μm, the surface in the range from 8 to 9 m / g and the vibrating weight in the range from 300 to 600 g / l.
Der Anteil der Magnesiumseifen an den erfindungsgemäßen Mit¬ teln kann üblicherweise 1 bis 15 und vorzugsweise 5 bis 10 Gew.-% ausmachen.The proportion of magnesium soaps in the agents according to the invention can usually make up 1 to 15 and preferably 5 to 10% by weight.
Co-EmulgatorenCo-emulsifiers
Die erfindungsgemäßen Mittel können als weitere Inhaltsstoffe Co-Emulgatoren enthalten, die ausgewählt sind aus der Gruppe von Estern von Fettsäuren mit Glycerin, Oligo- bzw. Polygly- cerinen und/oder Sorbitan. Typische Beispiele sind technische Mono- und/oder Diesterge- mische von C6-C22-Fettsänren mit Glycerin, technische Mono-, Di-, Tri- und/oder Tetraester von Cß-C22_Fettsä ren mit Oli- go- bzw. Polyglycerinen, die ihrerseits einen Eigenkondensa- tionsgrad im Bereich von 1,5 bis 10 aufweisen sowie techni¬ sche Mono-, Di- und/oder Triestergemische von C5-C22-Fett- säuren mit Sorbitan.The agents according to the invention can contain co-emulsifiers as further ingredients, which are selected from the group of esters of fatty acids with glycerol, oligo- or polyglycerols and / or sorbitan. Typical examples are technical mono- and / or Diesterge- mix of C6-C22 fatty änren with glycerol, technical mono-, di-, tri- and / or Tetraester of CSS C22 _Fetts ä ren go- with olive or polyglycerols which in turn have a degree of self-condensation in the range from 1.5 to 10 and technical mono-, di- and / or triester mixtures of C5-C22 fatty acids with sorbitan.
Besonders geeignet sind beispielsweise Glycerinmonolaurat, Glycerinmonopalmitat, Glycerinmonostearat, Glycerinmonooleat, Glycerinmono/distearat, Polyglycerindiisostearat, Polyglyce- rindioleat, Sorbitanmonolaurat , Sorbitanmonostearat, Sorbi- tansesquioleat, Sorbitandilaurat, Sorbitandipalmitat und Sor- bitantristearat.For example, glycerol monolaurate, glycerol monopalmitate, glycerol monostearate, glycerol monooleate, glycerol mono / distearate, polyglycerol diisostearate, polyglycerol dioleate, sorbitan monolaurate, sorbitan monostearate, sorbitan sesquioleate, sorbitol and sorbitan danduranate, are particularly suitable.
Der Anteil der Co-Emulgatoren an den erfindungsgemäßen Mit¬ teln kann üblicherweise 0,5 bis 20 und vorzugsweise 5 bis 15 Gew.-% ausmachen.The proportion of co-emulsifiers in the agents according to the invention can usually amount to 0.5 to 20 and preferably 5 to 15% by weight.
Herstellung der MittelProduction of funds
Zur Herstellung der Mittel empfiehlt es sich, zunächst die Magnesiumseife bei einer Temperatur unterhalb ihres Erwei¬ chungspunktes in der Komponente b) oder einem Teil davon zu lösen, die Lösung auf 50 bis 85°C abzukühlen und dann die weiteren Bestandteile einzurühren, wobei deren Reihenfolge unkritisch ist. Gewerbliche AnwendbarkeitFor the preparation of the agents, it is advisable to first dissolve the magnesium soap at a temperature below its softening point in component b) or a part thereof, to cool the solution to 50 to 85 ° C. and then to stir in the other constituents, their order is not critical. Industrial applicability
Die erfindungsgemäßen Mittel sind niedrigviskos, lagerstabil und lassen sich mit wäßrigen Phasen kalt emulgieren. Bei den resultierenden Emulsionen handelt es sich vorzugsweise um W/O-Emulsionen.The agents according to the invention are low viscosity, stable in storage and can be cold emulsified with aqueous phases. The resulting emulsions are preferably W / O emulsions.
Ein weiterer Gegenstand der Erfindung betrifft daher Emulsio¬ nen, enthaltend 5 bis 80, vorzugsweise 10 bis 60 Gew.-% der erfindungsgemäßen Mittel, 20 bis 80, vorzugsweise 25 bis 75 Gew.-% einer wäßrigen Phase und 0 bis 50, vorzugsweise 0 bis 25 Gew.-% Zusatzstoffen, mit der Maßgabe, daß sich die Men¬ genangaben zu 100 Gew.-% addieren.Another object of the invention therefore relates to emulsions containing 5 to 80, preferably 10 to 60% by weight of the agents according to the invention, 20 to 80, preferably 25 to 75% by weight of an aqueous phase and 0 to 50, preferably 0 up to 25% by weight of additives, with the proviso that the amounts given add up to 100% by weight.
Ein weiterer Gegenstand der Erfindung betrifft ferner ein Verfahren zur Herstellung von Emulsionen, bei dem man 5 bis 80, vorzugsweise 10 bis 60 Gew.-% der erfindungsgemäßen Mit¬ tel mit 20 bis 80, vorzugsweise 25 bis 75 Gew.-% einer wä߬ rigen Phase und 0 bis 50, vorzugsweise 0 bis 25 Gew.-% Zu¬ satzstoffen, mit der Maßgabe, daß sich die Mengenangaben zu 100 Gew.-% addieren, kalt emulgiert. Falls gewünscht, können an dieser Stelle auch weitere olkörper, Emulgatoren und Hilfsstoffe zugegeben und co-emulgiert werden.The invention further relates to a process for the preparation of emulsions, in which 5 to 80, preferably 10 to 60% by weight of the agents according to the invention are mixed with 20 to 80, preferably 25 to 75% by weight of an aqueous phase and 0 to 50, preferably 0 to 25% by weight of additives, with the proviso that the amounts add up to 100% by weight, cold emulsified. If desired, further oil bodies, emulsifiers and auxiliaries can also be added and co-emulsified at this point.
Unter dem Begriff "wäßrige Phase" ist Wasser sowie Gemische von Wasser mit niederen Alkoholen, wie z.B. Ethanol oder Iso- propylalkohol, oder Polyolen, wie z.B. Ethylenglycol, Diethy- lenglycol, Butylenglycol oder Glycerin zu verstehen. Die wäßrige Phase kann zudem Elektrolytsalze enthalten, wie z.B. Natriumchlorid, Magnesiumchlorid oder Magnesiumsulfat. Unter dem Begriff "kalt emulgiert" ist zu verstehen, daß die Bildung der Emulsion bei Umgebungstemperatur (20°C) durchge¬ führt werden kann, eine AufSchmelzung der Komponenten also nicht erforderlich ist.The term "aqueous phase" means water and mixtures of water with lower alcohols, such as ethanol or isopropyl alcohol, or polyols, such as ethylene glycol, diethylene glycol, butylene glycol or glycerin. The aqueous phase can also contain electrolyte salts, such as sodium chloride, magnesium chloride or magnesium sulfate. The term "cold emulsified" means that the Formation of the emulsion at ambient temperature (20 ° C) can be carried out, so melting of the components is not necessary.
Unter "Hilfsstoffe" sind beispielweise Parfümöle, Antioxidan- tien, Oxide und Pigmente, pH-Regulatoren, Farbstoffe und UV- Filter zu verstehen.“Auxiliaries” are understood to mean, for example, perfume oils, antioxidants, oxides and pigments, pH regulators, dyes and UV filters.
Ein letzter Gegenstand der Erfindung betrifft schließlich die Verwendung der erfindungsgemäßen Mittel zur Herstellung von kosmetischen oder pharmazeutischen Emulsionen, in denen sie in Mengen von 5 bis 80, vorzugsweise 10 bis 60 Gew.-% - be¬ zogen auf die Emulsionen - enthalten sein können. Finally, the invention relates to the use of the compositions according to the invention for the production of cosmetic or pharmaceutical emulsions, in which they can be present in amounts of 5 to 80, preferably 10 to 60% by weight, based on the emulsions.
BeispieleExamples
I. RezepturbestandteileI. Recipe components
AI) Anlagerungsprodukt von durchschnittlich 7 Mol Ethylen- oxid an hydriertes Ricinusöl (Dehymuls(R) HRE 7)AI) adduct of an average of 7 moles of ethylene oxide onto hydrogenated castor oil (Dehymuls ( R ) HRE 7)
Bl) Hexyllaurat (Cetiol(R) A)Bl) hexyl laurate (Cetiol ( R ) A)
B2) Octylstearat (Cetiol(R) 868)B2) octyl stearate (Cetiol ( R ) 868)
B3) Ceterylisononanoat (Cetiol(R) SN)B3) Ceterylisononanoate (Cetiol ( R ) SN)
B4) C8/10-Triglycerid (Myritol(R) 318) B4) C 8/10 triglyceride (Myritol (R) 318)
B5) MineralölB5) mineral oil
CI) Magnesiumstearat C2) Aluminiumstearat C3) ZinkεtearatCI) Magnesium stearate C2) Aluminum stearate C3) Zinc tearate
Dl) ölsäuremonoglycerid (Monomuls(R) 90-018) D2) Polyglycerindiisostearat (Lameform(R) TGI)Dl) oleic acid monoglyceride (Monomuls (R ) 90-018) D2) Polyglycerol diisostearate (Lameform ( R ) TGI)
Alle mit Warenzeichen gekennzeichneten Stoffe stellen Ver¬ kaufsprodukte der Henkel KGaA, Düεεeldorf/FRG dar. Die Rezep¬ turbestandteile Dl und D2 sind Verkaufsprodukte der CF Grünau, Illertissen/FRG. All substances marked with trademarks represent sales products of Henkel KGaA, Dusseldorf / FRG. The recipe components D1 and D2 are sales products of CF Grünau, Illertissen / FRG.
II. RezepturenII. Recipes
Zur Herstellung der kaltwasseremulgierbaren Mittel wurden die Metallseifen in Mineralöl gelöst, die Mischung auf 85°C ab¬ gekühlt und die übrigen Bestandteile eindosiert, wobei die Reihenfolge unkritisch war. Anschließend wurden die Disper¬ sionen auf Raumtemperatur abgekühlt. Die Lagerung erfolgte bei 45°C über einen Zeitraum von 4 Wochen. Die Zusammenεet- zung der erfindungsgemäßen Rezepturen (Beispiele 1 bis 5) sowie der Vergleichsrezepturen (Beispiele VI bis V5) sind Tab.1 zu entnehmen.To produce the cold water emulsifiable agents, the metal soaps were dissolved in mineral oil, the mixture was cooled to 85 ° C. and the other constituents were metered in, the sequence being uncritical. The dispersions were then cooled to room temperature. The storage took place at 45 ° C for a period of 4 weeks. The composition of the formulations according to the invention (Examples 1 to 5) and of the comparison formulations (Examples VI to V5) can be found in Table 1.
Tab.1; Erfindungsgemäße und Vergleichsrezepturen Prozentangaben als Gew.-%Tab. 1; Comparative formulations according to the invention, percentages as% by weight
Bsp. AI Bl B2 B3 B5 CI C2 C3 Dl D2Example AI Bl B2 B3 B5 CI C2 C3 Dl D2
% % % % % % % % % %%%%%%%%%%%
1 25 - — 28 29 8 - - 5 51 25 - - 28 29 8 - - 5 5
2 30 - 15 - 30 10 - - - 152 30 - 15 - 30 10 - - - 15
3 30 - 25 - 30 5 - - - 103 30 - 25 - 30 5 - - - 10
4 35 20 - - 25 10 - - 10 -4 35 20 - - 25 10 - - 10 -
5 32 - 18 - 31 6 - - - 135 32 - 18 - 31 6 - - - 13
VI 25 - - 28 29 - 8 - 5 5VI 25 - - 28 29 - 8 - 5 5
V2 30 - 15 - 30 - 10 - - 15V2 30 - 15 - 30 - 10 - - 15
V3 30 - 25 - 30 - 5 - - 10V3 30 - 25 - 30 - 5 - - 10
V4 35 20 - - 25 - - 10 10 -V4 35 20 - - 25 - - 10 10 -
V5 32 - 18 - 31 - - 6 - 13 Die Vergleichsrezepturen VI bis V5 zeigten bereits nach einer Lagerzeit von wenigen Tagen Entmischung. Das gleiche Ergebnis wurde auch bei einer Lagertemperatur von 20°C erzielt. Dem¬ gegenüber zeigten die erfindungsgemäßen Rezepturen 1 bis 5 bei 45°C über die gesamte Lagerzeit ein stabiles Phasenver¬ halten ohne Anzeichen einer Entmischung oder Sedimentation. V5 32 - 18 - 31 - - 6 - 13 The comparison formulations VI to V5 showed segregation after a storage time of just a few days. The same result was achieved at a storage temperature of 20 ° C. In contrast, the formulations 1 to 5 according to the invention showed a stable phase behavior at 45 ° C. over the entire storage period without any signs of segregation or sedimentation.
III. EmulsionenIII. Emulsions
Zur Herstellung der Emulsionen wurde die Fettphase I bei Um¬ gebungstemperatur homogen verrührt und die wäßrige Phase II kalt unter Rühren zugegeben. Die Emulsion wurde 5 bis 10 min nachgerührt und anschließend homogenisiert. Beispiele für Emulsionen sind in Tab.2 zusammengestellt:To prepare the emulsions, the fat phase I was stirred homogeneously at ambient temperature and the aqueous phase II was added cold while stirring. The emulsion was stirred for 5 to 10 minutes and then homogenized. Examples of emulsions are listed in Table 2:
Tab.2: EmulsionenTab. 2: Emulsions
Bsp. Komponenten Phase I Phase II Vis.E.g. components phase I phase II Vis.
Gew.% Gew.-% Paε% By weight% of Paε
6 Rezeptur 5 10 106 Recipe 5 10 10
B2 20B2 20
Glycerin (86 Gew.-%ig) 5Glycerin (86% by weight) 5
MgS04 * 7 H2° 1MgS04 * 7 H 2 ° 1
Wasser 64Water 64
7 Rezeptur 3 10 157 Recipe 3 10 15
B4 20B4 20
Glycerin (86 Gew.-%ig) 5Glycerin (86% by weight) 5
MgSθ4 * 7 H2O 1MgSO 4 * 7 H2O 1
Wasser 64Water 64
Legende; Viε = Viskosität nach Brookfield, RVF, 23°C,Legend; Viε = Brookfield viscosity, RVF, 23 ° C,
Spindel 5, 10 UpM Spindle 5, 10 rpm

Claims

Patentansprüche claims
1. Kaltwasseremulgierbare Mittel, enthaltend1. Containing cold water emulsifiable agents
a) 10 bis 40 Gew.-% eines Anlagerungsproduktes von 5 bis 15 Mol Ethylenoxid an hydrier¬ tes Ricinusöl, b) 30 bis 80 Gew.-% olkörper und c) 1 bis 15 Gew.-% Magnesiumεeife,a) 10 to 40% by weight of an adduct of 5 to 15 mol of ethylene oxide with hydrogenated castor oil, b) 30 to 80% by weight of oil body and c) 1 to 15% by weight of magnesium soap,
mit der Maßgabe, daß εich die Komponenten zu 100 Gew.-% addieren.with the proviso that the components add up to 100% by weight.
2. Mittel nach Anspruch 1, dadurch gekennzeichnet, daß sie olkörper enthalten, die ausgewählt sind aus der Gruppe, die gebildet wird von aliphatischen Kohlenwasserstoffen, Fettsäureester drei- oder mehrwertiger Alkohole, Mono- und Diester von Fettsäuren, Guerbetalkohole, Guerbet- eεter und Guerbetcarbonate.2. Composition according to claim 1, characterized in that they contain oil bodies which are selected from the group formed by aliphatic hydrocarbons, fatty acid esters of trihydric or polyhydric alcohols, mono- and diesters of fatty acids, Guerbet alcohols, Guerbet esters and Guerbet carbonates .
3. Mittel nach den Ansprüchen 1 und 2, dadurch gekennzeich¬ net, daß sie Magnesiumseifen der Formel (Ila) und/oder (Ilb) enthalten,3. Composition according to claims 1 and 2, characterized gekennzeich¬ net that they contain magnesium soaps of the formula (Ila) and / or (Ilb),
(R4COO)2Mg (Ha)(R 4 COO) 2Mg (Ha)
(R4COO)(OH)Mg (Ilb)(R 4 COO) (OH) Mg (Ilb)
in der R4CO für einen Fettacylrest mit 12 bis 22 Kohlen¬ stoffatomen steht. in which R 4 CO stands for a fatty acyl radical having 12 to 22 carbon atoms.
4. Mittel nach den Ansprüchen 1 bis 3, dadurch gekennzeich¬ net, daß sie als weitere Inhaltsstoffe Co-Emulgatoren enthalten, die ausgewählt sind aus der Gruppe von Eεtern von Fettεäuren mit Glycerin, Oligoglycerinen und/oder Sorbitan.4. Composition according to claims 1 to 3, characterized gekennzeich¬ net that they contain co-emulsifiers as further ingredients, which are selected from the group of esters of fatty acids with glycerol, oligoglycerols and / or sorbitan.
5. Mittel nach Anspruch 4, dadurch gekennzeichnet, daß die Co-Emulgatoren in Mengen von 0,5 bis 20 Gew.-% - bezogen auf die Mittel - enthalten sind.5. Composition according to claim 4, characterized in that the co-emulsifiers are present in amounts of 0.5 to 20 wt .-% - based on the composition.
6. Emulsionen, enthaltend 5 bis 80 Gew.-% der Mittel nach Anspruch 1, 20 bis 80 Gew.-% einer wäßrigen Phase und 0 bis 50 Gew.-% Zusatzεtoffe, mit der Maßgabe, daß sich die Mengenangaben zu 100 Gew.-% addieren.6. emulsions containing 5 to 80 wt .-% of the composition according to claim 1, 20 to 80 wt .-% of an aqueous phase and 0 to 50 wt .-% additives, with the proviso that the amount of 100 wt. - add%.
7. Verfahren zur Herstellung von Emulsionen, bei dem man 5 bis 80 Gew.-% der Mittel nach Anspruch 1 mit 75 bis 95 Gew.-% einer wäßrigen Phase und 0 bis 50 Gew.-% Zusatz¬ stoffen, mit der Maßgabe, daß sich die Mengenangaben zu 100 Gew.-% addieren, kalt emulgiert.7. A process for the preparation of emulsions, in which 5 to 80% by weight of the composition according to claim 1 is combined with 75 to 95% by weight of an aqueous phase and 0 to 50% by weight of additives, with the proviso that that the amounts add up to 100 wt .-%, cold emulsified.
8. Verwendung der kaltwasseremulgierbaren Mittel nach An¬ spruch 1 zur Herstellung von kosmetischen oder pharma¬ zeutischen Emulsionen. 8. Use of the cold water emulsifiable agents according to claim 1 for the production of cosmetic or pharmaceutical emulsions.
EP95900674A 1993-11-15 1994-11-07 Cold-water emulsifiable agents Ceased EP0729343A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4338999A DE4338999C1 (en) 1993-11-15 1993-11-15 Cold water-emulsifiable compositions
DE4338999 1993-11-15
PCT/EP1994/003642 WO1995013787A2 (en) 1993-11-15 1994-11-07 Cold-water emulsifiable agents

Publications (1)

Publication Number Publication Date
EP0729343A1 true EP0729343A1 (en) 1996-09-04

Family

ID=6502653

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95900674A Ceased EP0729343A1 (en) 1993-11-15 1994-11-07 Cold-water emulsifiable agents

Country Status (5)

Country Link
EP (1) EP0729343A1 (en)
JP (1) JPH09505235A (en)
CN (1) CN1135169A (en)
DE (1) DE4338999C1 (en)
WO (1) WO1995013787A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19539428A1 (en) * 1995-10-24 1997-04-30 Beiersdorf Ag Emulsifier-free finely dispersed cosmetic or dermatological preparations of the water-in-oil type
JPH10194923A (en) * 1997-01-13 1998-07-28 Nippon Zetotsuku Kk Emulsified composition
DE19814608C1 (en) * 1998-04-01 1999-09-23 Henkel Kgaa Preparation of viscosified cosmetic cleansing compositions, e.g. shampoos, hair rinses, shower baths or cleansing lotions, without heating
DE19829647A1 (en) 1998-07-02 2000-01-13 Wella Ag Process for the preparation of aqueous emulsions or suspensions
CN103006681B (en) * 2012-12-04 2014-07-09 哈尔滨乐泰药业有限公司 Compound emulsifiable paste for treating acne and preparation method thereof
EP2992949A1 (en) 2014-09-03 2016-03-09 The Procter and Gamble Company Method for producing aqueous emulsions or suspensions
EP2992950A1 (en) 2014-09-03 2016-03-09 The Procter and Gamble Company Method for producing aqueous emulsions or suspensions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4243119A1 (en) * 1992-12-22 1994-06-23 Henkel Kgaa Water repellent baby cream

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9513787A2 *

Also Published As

Publication number Publication date
JPH09505235A (en) 1997-05-27
CN1135169A (en) 1996-11-06
WO1995013787A3 (en) 1995-07-06
WO1995013787A2 (en) 1995-05-26
DE4338999C1 (en) 1994-10-13

Similar Documents

Publication Publication Date Title
EP0554292B1 (en) Oil-in-water emulsions
DE19641604C1 (en) Polyglycerol partial esters of fatty acids and polyfunctional carboxylic acids, their preparation and use
EP1732877B1 (en) Sensory wax for cosmetic and/or pharmaceutical formulations
EP0618840B1 (en) Method of producing oil-in-water emulsions
DE3010879A1 (en) EMULSIFIER COMPOSITION
WO1995011936A2 (en) Process for producing wax dispersions
DE3819193A1 (en) METHOD FOR PRODUCING STABLE, LOW-VISCUS OIL-IN-WATER EMULSIONS OF POLAR OIL COMPONENTS
EP0845978B1 (en) Translucent antiperspirants/deodorants
EP0723432B1 (en) Free flowing emulsion concentrate
WO1995011660A1 (en) Process for producing oil-in-water emulsions
EP2465486A2 (en) W/O emulsions
DE4407015C2 (en) Cosmetic and / or pharmaceutical preparations
WO1995013787A2 (en) Cold-water emulsifiable agents
EP1071466B2 (en) Glycolipid creams
EP2769707B1 (en) Water-oil emulsions with multilayer pigment capsules
DE19541753C2 (en) Cosmetic and / or pharmaceutical emulsions
EP0986364B1 (en) Multiple water/oil/water emulsions with a high polyol content
WO1993005129A1 (en) Emulsions of polar oils in water
DE4023600A1 (en) FLOWABLE, STORAGE-STABLE DISPERSIONS OF FATTY ACID PARTIAL GLYCERIDES
DE19646878A1 (en) Cosmetic oil-in-water emulsion preparation

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19960506

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): BE DE ES FR GB IT NL

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

17Q First examination report despatched

Effective date: 19980130

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 19980817